Skip to main content

and
  1. Article

    Open Access

    Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial

    Sanjeev Sinha, Anuj Ajayababu, Himanshu Thukral in Infectious Diseases and Therapy (2023)

  2. Article

    Open Access

    Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial

    Universal coverage of vaccines alone cannot be relied upon to protect at-risk populations in lower- and middle-income countries against the impact of the coronavirus disease 2019 (COVID-19) pandemic and newer ...

    Sanjeev Sinha, Anuj Ajayababu, Himanshu Thukral in Infectious Diseases and Therapy (2022)